Your browser doesn't support javascript.
loading
A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.
Taira, Makiko; Imamura, Minako; Takahashi, Atsushi; Kamatani, Yoichiro; Yamauchi, Toshimasa; Araki, Shin-Ichi; Tanaka, Nobue; van Zuydam, Natalie R; Ahlqvist, Emma; Toyoda, Masao; Umezono, Tomoya; Kawai, Koichi; Imanishi, Masahito; Watada, Hirotaka; Suzuki, Daisuke; Maegawa, Hiroshi; Babazono, Tetsuya; Kaku, Kohei; Kawamori, Ryuzo; Groop, Leif C; McCarthy, Mark I; Kadowaki, Takashi; Maeda, Shiro.
Affiliation
  • Taira M; Laboratory for Endocrinology, Metabolism and Kidney Diseases, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Imamura M; Laboratory for Endocrinology, Metabolism and Kidney Diseases, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Takahashi A; Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Kamatani Y; Division of Clinical Laboratory and Blood Transfusion, University of the Ryukyus Hospital, Okinawa, Japan.
  • Yamauchi T; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Araki SI; Department of Genomic Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Tanaka N; Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • van Zuydam NR; Kyoto-McGill International Collaborative School in Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Ahlqvist E; Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Toyoda M; Department of Medicine, Shiga University of Medical Science, Shiga, Japan.
  • Umezono T; Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
  • Kawai K; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Imanishi M; Oxford Center for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Watada H; Department of Clinical Sciences, Diabetes and Endocrinology, Lund University Diabetes Centre, Scania University Hospital, Malmö, Sweden.
  • Suzuki D; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Maegawa H; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
  • Babazono T; Kawai Clinic, Ibaragi, Japan.
  • Kaku K; Division of Nephrology and Hypertension, Department of Internal Medicine, Osaka City General Hospital, Osaka, Japan.
  • Kawamori R; Department of Nephrology, and Hemodialysis Unit, Ishikiriseiki Hospital, Higashi-Osaka, Japan.
  • Groop LC; Sportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • McCarthy MI; Suzuki Diabetes Clinic, Kanagawa, Japan.
  • Kadowaki T; Department of Medicine, Shiga University of Medical Science, Shiga, Japan.
  • Maeda S; Diabetes Center, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
PLoS One ; 13(12): e0208654, 2018.
Article in En | MEDLINE | ID: mdl-30566433
To explore novel genetic loci for diabetic nephropathy, we performed genome-wide association studies (GWAS) for diabetic nephropathy in Japanese patients with type 2 diabetes. We analyzed the association of 5,768,242 single nucleotide polymorphisms (SNPs) in Japanese patients with type 2 diabetes, 2,380 nephropathy cases and 5,234 controls. We further performed GWAS for diabetic nephropathy using independent Japanese patients with type 2 diabetes, 429 cases and 358 controls and the results of these two GWAS were combined with an inverse variance meta-analysis (stage-1), followed by a de novo genotyping for the candidate SNP loci (p < 1.0 × 10(-4)) in an independent case-control study (Stage-2; 1,213 cases and 1,298 controls). After integrating stage-1 and stage-2 data, we identified one SNP locus, significantly associated with diabetic nephropathy; rs56094641 in FTO, P = 7.74 × 10(-10). We further examined the association of rs56094641 with diabetic nephropathy in independent Japanese patients with type 2 diabetes (902 cases and 1,221 controls), and found that the association of this locus with diabetic nephropathy remained significant after integrating all association data (P = 7.62 × 10(-10)). We have identified FTO locus as a novel locus for conferring susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Alpha-Ketoglutarate-Dependent Dioxygenase FTO Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Predisposition to Disease / Polymorphism, Single Nucleotide / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Alpha-Ketoglutarate-Dependent Dioxygenase FTO Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2018 Type: Article Affiliation country: Japan